FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

FDA Accepts Resubmission for RP1 Oncolytic Immunotherapy Plus Nivolumab in PD-1–Refractory Melanoma

OncoDaily Party Berlin 2025: A Night Where Oncology Met Energy

OncoDaily Party Berlin 2025 ESMO

100 Influential People in Oncology 2025 - Nominations are Open!

100 Influential People in Oncology 2025

Katy Rezvani: Comprehensive Overview of Engineered Natural Killer Cells for Cancer Therapy

Katy Rezvani

Iza-bren (EGFR×HER3 bispecific ADC) 303 Study: Late-breaking ESMO presentation, The Lancet publication, and press-conference Q&A highlights

iza-bren egfrxher3 bispecific press release

Enrique Soto: New ASCO Global Guideline on Geriatric Assessment

Enrique Soto

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

International Cardio-Oncology Society Introduced the GCOS 2025 Social Media Ambassador Team

Zihai Li: First-In-Human Anti-GARP CAR-T Trial for Patients With Relapsed GBM

Zihai Li

OncoCalendar

Loading Events

« All Events

  • This event has passed.

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

Mar 25 • 12:00 AM - Mar 29 • 12:00 AM
Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM)

Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) will be held from March 25, 2025 – May 29, 2026. It’s a hybrid event and the offline venues will change either.

The Certificate of Advanced Studies in Thoracic Malignancies (CAS-TM) is a joint collaboration between the European School of Oncology (ESO) and the University of Fribourg, Switzerland.  The programme will focus on the improvement on both the clinical and the scientific aspects of improving quality in the management of patients with lung cancer and other thoracic malignancies.  Upon successful completion of the programme, participants will obtain an academic certificate assigning 14 ECTS credits, equalling a work load of 420 hours and a diploma supplement by the University of Fribourg.